Copyright 1999 American Medical Association.
All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.1999
To the Editor: Dr Nakashima and
colleagues1 conclude that mandatory name-based reporting
did not appear to affect human immunodeficiency virus (HIV) testing use
in publicly funded testing programs. There are several problems with
First, the study did not include a comparison group adequate to allow a
national-level conclusion. While the authors did compare rates before
and after testing, they did not include any analysis of states in which
name-based reporting was not instituted. Thus, it is impossible for the
authors to prove that testing rates might not have increased more
dramatically in the states studied had name-based reporting not been
Aragón R, Myers J. HIV Testing After Implementation of Name-Based Reporting. JAMA. 1999;281(15):1377–1380. doi:10-1001/pubs.JAMA-ISSN-0098-7484-281-15-jbk0421
Customize your JAMA Network experience by selecting one or more topics from the list below.